Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+62.4%
5Y CAGR+43.5%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+62.4%/yr
vs +63.9%/yr prior
5Y CAGR
+43.5%/yr
Recent acceleration
Acceleration
-1.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.1x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.26B+85.6%
2024$678.01M+78.2%
2023$380.50M+29.6%
2022$293.57M+21.1%
2021$242.48M+17.3%
2020$206.67M+117.6%
2019$94.97M+133.4%
2018$40.68M+26.9%
2017$32.06M+27.1%
2016$25.22M-